Aurinia Pharmaceuticals
AUPH
AUPH
123 hedge funds and large institutions have $878M invested in Aurinia Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 39 increasing their positions, 26 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
8% more funds holding
Funds holding: 114 → 123 (+9)
11% less capital invested
Capital invested by funds: $991M → $878M (-$113M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
123
Holding in Top 10
5
Calls
$34.3M
Puts
$28M
Top Buyers
| 1 | +$71.7M | |
| 2 | +$25M | |
| 3 | +$23.4M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$15.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$15.6M |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$14.6M | |
| 3 | -$14.5M | |
| 4 |
CLCM
Crawford Lake Capital Management
Lakewood,
New Jersey
|
-$7.25M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$6.33M |